Stockreport

CRISPR Therapeutics (CRSP) Is Down 7.1% After Slower Casgevy Rollout and Wider 2025 Net Loss – What's Changed [Yahoo! Finance]

CRISPR Therapeutics AG - Common Shares  (CRSP) 
Last crispr therapeutics ag - common shares earnings: 8/7 05:01 pm Check Earnings Report
US:NASDAQ Investor Relations: nasdaq.com/symbol/crsp/real-time
PDF thalassemia has been slower than hoped, contributing to a 2025 net loss of about US$581.60 million despite holding roughly US$2.00 billions in cash and marketable securi [Read more]